The relationship between the number of generic drugs and pricing within a therapeutic class
- At: 2014 FIP Congress in Bangkok (Thailand)
- Type: Poster
- By: SULEMAN, Fatima (University of KwaZulu-Natal, Pharmaceutical Sciences, Durban, South Africa)
- Co-author(s): Bangalee, Varsha (University of KwaZulu-Natal, Durban, South Africa)
Background: This research focuses on pricing competition in South Africa, where concurrent pricing legislation, is being implemented without monitoring of the consequences on generic drug competition and usage.
Aim: To examine the relationship between generic drug competition and the number of brands and to compare South African private sector.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.